MedKoo Cat#: 581628 | Name: Deanol acetamidobenzoate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Deanol acetamidobenzoate is CNS stimulant. It can be caused elevated blood choline levels, can be used in Treatment of Choreiform Movement Disorders.

Chemical Structure

Deanol acetamidobenzoate
Deanol acetamidobenzoate
CAS#3635-74-3

Theoretical Analysis

MedKoo Cat#: 581628

Name: Deanol acetamidobenzoate

CAS#: 3635-74-3

Chemical Formula: C13H18N2O3

Exact Mass: 250.1317

Molecular Weight: 250.30

Elemental Analysis: C, 62.38; H, 7.25; N, 11.19; O, 19.18

Price and Availability

This product was removed for the commercial reasons.
Related CAS #
No Data
Synonym
Deanol acetamidobenzoate; Cervoxan; Deaner; Deanol p-acetamidobenzoate; Diforene; Elevan; Nervoton.
IUPAC/Chemical Name
2-(Dimethylamino)ethanol p-acetylaminobenzoate
InChi Key
FZLZGULUHIGIOT-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H18N2O3/c1-10(16)14-12-6-4-11(5-7-12)13(17)18-9-8-15(2)3/h4-7H,8-9H2,1-3H3,(H,14,16)
SMILES Code
CN(CCOC(C1=CC=C(NC(C)=O)C=C1)=O)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 250.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Hughes EC, Brackmann DE, Weinstein RC. Seventh nerve spasm: effect of modification of cholinergic balance. Otolaryngol Head Neck Surg. 1980 Jul-Aug;88(4):491-9. PubMed PMID: 6821438. 2: de Montigny C, Chouinard G, Annable L. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study. Psychopharmacology (Berl). 1979 Nov;65(3):219-23. PubMed PMID: 117492. 3: Millington WR, McCall AL, Wurtman RJ. Deanol acetamidobenzoate inhibits the blood-brain barrier transport of choline. Ann Neurol. 1978 Oct;4(4):302-6. PubMed PMID: 727735. 4: Penovich P, Morgan JP, Kerzner B, Karch F, Goldblatt D. Double-blind evaluation of deanol in tardive dyskinesia. JAMA. 1978 May 12;239(19):1997-8. PubMed PMID: 347112. 5: Stafford JR, Fann WE. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia. Dis Nerv Syst. 1977 Dec;38(12 Pt 2):3-6. PubMed PMID: 590063. 6: Tarsy D, Bralower M. Deanol acetamidobenzoate treatment in choreiform movement disorders. Arch Neurol. 1977 Dec;34(12):756-8. PubMed PMID: 145212. 7: Ray I. Tardive dyskinesia treated with deanol acetamidobenzoate. Can Med Assoc J. 1977 Jul 23;117(2):129. PubMed PMID: 872010; PubMed Central PMCID: PMC1879685. 8: Curran DJ, Nagaswami S, Mohan KJ. Treatment of phenothiazine induced bulbar persistent dyskinesia with deanol acetamidobenzoate. Dis Nerv Syst. 1975 Feb;36(2):71-3. PubMed PMID: 1116418. 9: JACOBS J. A CONTROLLED TRIAL OF DEANER AND A PLACEBO IN MENTALLY DEFECTIVE CHILDREN. Br J Clin Pract. 1965 Feb;19:77-86. PubMed PMID: 14260059. 10: BOSTOCK J, SHACKLETON M. The use of DMAE ("Deaner") in behaviour states. Med J Aust. 1962 Sep 1;49(2):337-9. PubMed PMID: 14014225. 11: REBOLLO MA, CASAS M. [Use of "Deaner" (deanol) in children with clinical and/or electroencephalographic epilepsy]. Arch Pediatr Urug. 1961 Sep;32:514-9. Spanish. PubMed PMID: 14490836. 12: MORIARTY JD, MEBANE JC. Clinical experiences with deanol (deaner): a different type of "psychic energizer". J Neuropsychiatr. 1959 Sep-Oct;1:26-7. PubMed PMID: 14424158. 13: BARSA JA, SAUNDERS JC. Deanol (deaner) in the treatment of schizophrenia. Am J Psychiatry. 1959 Sep;116:255-6. PubMed PMID: 13797141. 14: PENNINGTON VM. Clinical results with the use of deanol (deaner) in schizophrenia. Am J Psychiatry. 1959 Aug;116:165-6. PubMed PMID: 14431616. 15: MORIARTY JD, MEBANE JC. Clinical uses of deanol (deaner): a new type of psychotropic drug. Am J Psychiatry. 1959 Apr;115(10):941-2. PubMed PMID: 13637266. 16: MELLER RL. Treatment of mild depression with deanol para-acetamidobenzoate. J Lancet. 1959 Jan;79(1):25-6. PubMed PMID: 13621059. 17: TOLL N. Deaner an adjunct for treatment of schizoid and schzophrenic patients. Am J Psychiatry. 1958 Oct;115(4):366-7. PubMed PMID: 13583235. 18: LEMERE F, LASATER JH. Deanol (deaner) a new cerebral stimulant for the treatment of neurasthenia and mild depression: a preliminary report. Am J Psychiatry. 1958 Jan;114(7):655-6. PubMed PMID: 13487816.